adjuvant pembrolizumab and survival in renal-cell carcinoma | nejm
Published 3 months ago • 1.1K plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
2:12
neoadjuvant pembrolizumab for lung cancer | nejm
-
2:23
enfortumab vedotin–pembrolizumab in advanced urothelial cancer | nejm
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
2:13
treating advanced renal-cell carcinoma
-
2:24
perioperative nivolumab in resectable nsclc | nejm
-
2:00
ribociclib in early breast cancer | nejm
-
1:00
adjuvant pembrolizumab in kidney cancer from keynote 564
-
2:05
pembrolizumab as second-line therapy for advanced urothelial carcinoma
-
1:00
adjuvant pembrolizumab for bladder cancer
-
1:03
potential of adjuvant therapy for rcc
-
3:07
pembrolizumab, sabr develop a rapport for oligometastatic rcc | shankar siva
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
24:30
s1 episode 4: managing lung cancer with neoadjuvant and adjuvant therapy
-
0:35
the latest developments in adjuvant therapy for rcc
-
5:33
keynote-564: pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with...
-
43:38
adjuvant pembrolizumab after nephrectomy in rcc (nejm aug 2021) - joão guilherme (r2 urologia uerj)
-
9:29
keynote-564 study
-
3:01
a phase iii trial of pembrolizumab as adjuvant treatment for renal cell carcinoma